| Protein Name |
Myocyte-specific enhancer factor 2D |
| Gene |
MEF2D |
| UniProt |
Q01484 |
| Molecular Weight |
55.4 kDa |
| Length |
507 amino acids |
| Subcellular Localization |
Nucleus |
| Protein Family |
MEF2 transcription factor family |
Mef2D Protein Myocyte Enhancer Factor 2D is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
MEF2D (Myocyte-specific enhancer factor 2D) is a transcription factor protein encoded by the MEF2D gene. It belongs to the MEF2 family of transcription factors, which are essential for neuronal development, survival, synaptic plasticity, and activity-dependent gene expression.1
The protein is a DNA-binding protein that recognizes the Mef2 consensus sequence (TTATTTATA) and regulates target gene expression in response to neuronal activity and various signaling pathways.
¶ Domain Architecture
MEF2D contains several functional domains:
- MADS-box domain (MHF1 region): Amino acids 1-56 - DNA-binding and dimerization domain
- MEF2 domain: Amino acids 85-127 - Protein-protein interactions and cofactor binding
- Transactivation domain (TAD): Carboxy-terminal region - Contains serine-rich and acidic regions for transcriptional activation
- Serine-rich region: Multiple serine residues that can be phosphorylated
MEF2D undergoes several post-translational modifications:
- Phosphorylation: Multiple serine/threonine kinases phosphorylate MEF2D, including CaMK, MAPK, and PKC
- Acetylation: p300/CBP can acetylate MEF2D, affecting its transcriptional activity
- Sumoylation: MEF2D can be sumoylated, which typically represses its activity
- Proteolytic cleavage: Caspase cleavage generates truncated forms with pro-apoptotic activity
MEF2D is a transcriptional activator that regulates genes involved in:
- Neuronal survival: Activates expression of anti-apoptotic proteins and neurotrophic factors
- Synaptic plasticity: Controls genes encoding synaptic vesicle proteins, PSD proteins, and ion channels
- Metabolism: Regulates genes involved in mitochondrial function and energy metabolism
- Cell differentiation: Controls neuronal differentiation and maturation programs
MEF2D integrates signals from multiple pathways:
- Calcium signaling: Ca2+/calmodulin-dependent kinases (CaMK) activate MEF2
- MAPK/ERK pathway: ERK signaling enhances MEF2 transcriptional activity
- PI3K/Akt pathway: Akt phosphorylates and activates MEF2
- cAMP signaling: PKA can modulate MEF2 activity
In Parkinson's disease, MEF2D function is impaired in dopaminergic neurons. Studies show:
- MEF2D activity is reduced in PD models
- MEF2D interacts with Parkin and PINK1, proteins involved in mitophagy
- Restoring MEF2D protects neurons from mitochondrial toxins
- MEF2D regulates expression of dopaminergic neuron-specific genes
MEF2D dysregulation contributes to motor neuron degeneration in ALS:
- Altered MEF2D expression and activity in ALS models
- MEF2D regulates genes important for motor neuron survival
- Therapeutic approaches targeting MEF2D are being explored
MEF2 is involved in synaptic dysfunction in AD:
- MEF2 activity is altered in AD models
- MEF2 regulates synaptic plasticity genes affected in AD
MEF2D function is impaired in HD:
- Transcriptional dysregulation of MEF2 target genes
- MEF2D mediates some effects of mutant huntingtin
Research is exploring small molecules that can enhance MEF2D activity:
- Compounds that increase MEF2D phosphorylation
- Histone deacetylase (HDAC) inhibitors that enhance MEF2D-mediated transcription
- Viral vectors expressing MEF2D
- CRISPR-based approaches to enhance MEF2D expression
Key kinases that regulate MEF2D activity are potential drug targets:
- CaMK inhibitors/activators
- MAPK pathway modulators
- Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science, 1999.
- Activity-dependent regulation of MEF2 transcription factors in the nervous system. Genes & Development, 2006.
- Myocyte enhancer factor 2D mediates mitochondria-dependent apoptosis in Parkinson's disease. Neurobiology of Aging, 2014.
- MEF2D polymorphisms and susceptibility to amyotrophic lateral sclerosis. PLOS ONE, 2015.
The study of Mef2D Protein Myocyte Enhancer Factor 2D has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Mao Z et al., Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science, 1999. DOI
- Flavell SW et al., Activity-dependent regulation of MEF2 transcription factors in the nervous system. Genes & Development, 2006. DOI
- Yang Y et al., Myocyte enhancer factor 2D mediates mitochondria-dependent apoptosis in Parkinson's disease. Neurobiology of Aging, 2014. DOI
- Zhang Z et al., MEF2D polymorphisms and susceptibility to amyotrophic lateral sclerosis. PLOS ONE, 2015. DOI
- UniProt: MEF2D
Page auto-generated from NeuroWiki protein database.